A new study led by a researcher at New York Institute of Technology provides insight that could change how scientists and clinicians understand genetic predisposition to breast cancer, a condition that affects one in eight U.S. women in her lifetime.
New issue of Toxicological Sciences features a Systematic Review on PFAS exposure during breastfeeding, an In-Depth Review on PFAS toxicokinetics and modes of action, and spotlight articles on an in vitro rat airway epithelial model and on risk estimates for lead based on drinking water, genetics, and diet.
Susan G. Komen®, the world’s leading breast cancer organization, will be hosting the annual 2023 Seattle MORE THAN PINK Walk on Saturday, September 23. The annual Walk will be held for the first time at Woodland Park Zoo.
Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor therapies, they halt tumor progression in mice models.
Women with larger breasts tend to exercise less frequently and avoid high-intensity exercise and a new study has found much improved participation in recreational group exercises after breast reduction surgery.
The center will develop and evaluate innovative approaches to reduce pregnancy-related complications and deaths and promote maternal health equity in the Gulf South.
Pregnant women that live in walkable communities—with more sidewalks, parks and walking paths—not only engage in more physical activity but are also more likely to experience favorable birth outcomes, according to research from the University of New Hampshire.
Researchers at Tel Aviv University have developed a computational model that makes it possible to predict each woman's genetic risk of developing breast cancer based on her genetic profile.
Vaginal estrogen cream, which is commonly prescribed to help women after surgery for pelvic organ prolapse (POP), did not prevent a recurrence of the condition, according to results of a multicenter clinical trial led by UT Southwestern Medical Center. However, the medication did reduce symptoms of vaginal atrophy. The findings, reported in JAMA, could lead to new ways to improve outcomes of prolapse repairs, the study authors said.
Women are at significantly greater risk of depression following brain injury than men. People with opioid use disorder are nearly five times more likely to overdose following surgery. Black, Hispanic and Asian children are less likely to receive tubes commonly used to treat ear infections. These findings are among the significant research to be unveiled at ANESTHESIOLOGY® 2023, the annual meeting of the American Society of Anesthesiologists (ASA), Oct. 13-17 in San Francisco.
Researchers analyzed over 100 period products for fluorinated compounds, an indicator of potentially harmful per- and polyfluoroalkyl substances, or PFAS. While PFAS were absent from many products, they might be in others. They will present their results at ACS Fall 2023.
Uninsured and underinsured women who make an appointment can receive free cervical and breast cancer screenings as part of Loyola Medicine's 8th annual See, Test and Treat® event on Saturday, August 19, 2023. Over the past seven years, the event has provided 299 women with screenings.
A Kaiser Permanente study provides new information that may help oncologists answer one of the most common questions they hear from breast cancer survivors: Is it safe to drink alcohol?
Nanozymes—artificial enzymes that can carry out pre-determined chemical reactions—could selectively activate a cancer drug within a tumor while minimizing damage to healthy tissue in a mouse model of triple negative breast cancer.
Breast cancer screening for women over 70 is not without risks, according to new research from Yale School of Medicine’s COPPER Center. Although some guidelines recommend continuing screening for older women, a new study emphasizes the importance of assessing potential harms associated with testing, such as overdiagnosis, which, researchers say, can negatively affect quality of life.
Not for public release
This news release is embargoed until 7-Aug-2023 5:00 PM EDT
Released to reporters: 1-Aug-2023 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 7-Aug-2023 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Not for public release
This news release is embargoed until 7-Aug-2023 5:00 PM EDT
Released to reporters: 1-Aug-2023 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 7-Aug-2023 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
إن تناول المشروبات الكحولية باعتدال هو مفتاح التمتع بصحة جيدة، خاصةً للنساء اللواتي يحاولن التخفيف من أعراض انقطاع الطمث، وفقًا لخبيرة صحة المرأة في مايو كلينك. قد يؤدي تناول المشروبات الكحولية أثناء انقطاع الطمث إلى تفاقم الأعراض وارتفاع خطر الإصابة بمشكلات صحية خطيرة لدى النساء، مثل أمراض القلب وهشاشة العظام، وذلك وفقًا للدكتورة جوليانا كلينج، دكتور في الطب، المدير المساعد لمركز صحة المرأة في مايو كلينك بولاية أريزونا.
Not for public release
This news release is embargoed until 7-Aug-2023 2:05 PM EDT
Released to reporters: 7-Aug-2023 2:05 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 7-Aug-2023 2:05 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
One common side effect of treatment for ovarian cancer is chemotherapy-induced peripheral neuropathy (CIPN), which can damage peripheral nerves, causing severe pain and numbness. The effects can last for months – or even years — after completing chemotherapy. Currently, there is only one treatment with limited efficacy for CIPN.
The August issue of The American Journal of Gastroenterology includes several articles on digital therapeutics and innovations in GI, encouraging adoption of emerging GI technologies to advance GI care.
The National Cancer Institute (NCI) has awarded a 5-year, $2.7 million grant to researchers at Sanford Burnham Prebys to investigate and elucidate the underlying cellular mechanisms that drive the most common form of breast cancer.
Beber alcohol con moderación es clave para una buena salud, en especial para las mujeres que intentan minimizar los síntomas de la menopausia, de acuerdo con una experta en salud femenina de Mayo Clinic.
O consumo de álcool com moderação é o segredo para a boa saúde, especialmente para as mulheres que estão tentando minimizar os sintomas da menopausa, de acordo com a especialista em saúde da mulher da Mayo Clinic.
Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School of Medicine at Mount Sinai and colleagues have identified a 64-protein signature that may predict a subset of ovarian cancer patients who are unlikely to respond to chemotherapy. The multicenter study, published online August 3 in Cell, reports on a pioneering analysis of chemo-refractoriness in high-grade serous ovarian cancer (HGSOC). The work also implicates possible therapeutic targets for these patients.
The Birrer Laboratory at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute helped discover a proteogenomic signature in ovarian cancer that may improve the way the disease is treated around the world. The discovery, which identifies a 64-protein-gene signature that can predict primary treatment resistance in patients with high grade ovarian cancer, was published Aug. 3 in the journal Cell.
Susan G. Komen®, the world’s leading breast cancer organization, today announced the renaming of a metastatic breast cancer (MBC) grant to honor Rhonda Crocker Howell, a Raleigh resident, community leader and dedicated breast cancer advocate. The grant will be renamed The Susan G. Komen Metastatic Breast Cancer Collaborative Research Grant in honor of Rhonda Crocker Howell.
A survey of new Australian mums released in World Breastfeeding Week (1-7 August) reveals that a quarter of their workplaces did not provide appropriate breastfeeding facilities when returning from maternity leave.
Mammography screening supported by artificial intelligence (AI) is a safe alternative to today’s conventional double reading by radiologists and can reduce heavy workloads for doctors.
One year after the Dobbs decision, 41.8% of U.S. women of reproductive age have to drive 30 minutes or more to reach an abortion care facility, according to a study of data as of June 2, 2023. Researchers predicted that number would rise to 53.5% if other state bills under consideration are passed.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Recent developments include a novel biomarker that may predict the aggressiveness of pancreatic cancer precursors, insights into the structure and function of a breast and ovarian cancer susceptibility gene, a new approach to overcoming treatment resistance in ovarian cancer, distinguishing features of young-onset rectal cancer, a biomarker and potential target for metastatic lung cancer, machine learning models to better predict outcomes of patients with mantle cell lymphoma (MCL), and a promising therapy for patients with relapsed/refractory MCL.
Cedars-Sinai Cancer investigators are spearheading a project, funded by a five-year, $11.2 million grant from the National Cancer Institute, part of the National Institutes of Health, to advance scientific knowledge of how biological differences between men and women affect bladder cancer.
Hackensack Meridian Mountainside Medical Center is proud to announce the introduction of Cerianna, an advanced breast imaging technology, further solidifying its commitment to providing cutting-edge healthcare services to the community.
Smoking in pregnancy can harm developing babies, especially their growth . Current guidelines recommend that pregnant smokers who find quitting difficult should be provided with nicotine replacements products and stop-smoking services usually recommend nicotine patches.
More than 4 out of 5 older women survivors of colorectal cancer may be experiencing a range of gastrointestinal symptoms many years after being diagnosed and treated, a new study suggests.
On World Lung Cancer Day, Aug. 1, the Forum of International Respiratory Societies (FIRS) and its founding member, the American Thoracic Society, stress the importance of understanding lung cancer risk factors, as well as the importance of early detection through screening, and treatment.
The study finds utilization of annual screening mammograms suboptimal among low-income Black women with several reported perceived and actual barriers. Most had a low breast cancer risk perception. Interestingly, participants perceived mammograms as very beneficial: 80 percent believed that ‘if breast cancer is found early, it’s likely that the cancer can be successfully treated;’ 90 percent indicated that ‘having a mammogram could help find breast cancer when it is first getting started.’
Hackensack Meridian Health orthopedic experts available to discuss ACL injuries, prevention, recovery and new procedures to treat the injury that is common in female athletes including in this World Cup
A first-of-its kind drug for prostate cancer, an ancient retrovirus that may drive aggressive brain cancer, disparities in endometrial cancer rates among Black women, a new trial seeking answers for higher rates of aggressive prostate and breast cancer in Black men and women, and more are in this month’s tip sheet from Sylvester Comprehensive Cancer Center.
Though it’s just as likely to be worn while lounging on the couch as in the gym, a large driver of activewear’s popularity among women is its association with a dynamic lifestyle, positive wellbeing and overall good health. However, two new Edith Cowan University (ECU) studies suggest online shopping for activewear may in fact be harmful to women’s body image.
A new study provides evidence for the possibility that mitochondrial dysregulation could be a contributing factor in the development of hypertensive disorders of pregnancy. The study is published in Physiological Genomics. It was chosen as an APSselect article for July.
Susan G. Komen®, the world’s leading breast cancer organization, announced the fourth MBC-focused research grant supported through the Komen Metastatic Breast Cancer Collaborative Research Initiative (MBCCRI), a collaboration between Komen, Duke Cancer Institute and the University of North Carolina Lineberger Comprehensive Cancer Center, which pairs researchers from each of the organizations to work together and address significant gaps in our knowledge about MBC to advance patient care and improve patient outcomes.
Undernutrition during pregnancy is one of the factors linked to an increased risk of diseases in children as they grow older. Yet, maternal malnutrition remains a problem for women worldwide.
Susan G. Komen commends commends the introduction of the Access to Breast Cancer Diagnosis (ABCD) Act of 2023 in the U.S. House of Representatives and the U.S. Senate. The legislation would remove a significant financial barrier to people receiving medically necessary diagnostic and supplemental breast imaging.